EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects.
Wirges A, Bunse M, Joedicke JJ, Blanc E, Gudipati V, Moles MW, Shiku H, Beule D, Huppa JB, Höpken UE, et al. Mol Ther. 2022 Nov 2; 30(11):3358-3378. Epub 2022 Jul 12.